eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | intestinal disease |
| Comorbidity | C0376545|hematologic malignancies |
| Sentences | 1 |
| PubMedID- 23955181 | Background: although attention has been focused for over 20 years on the possible increased risk for hematologic malignancies (hm) in patients with inflammatory bowel diseases (ibd) receiving immune-modulators or anti-tnf-alpha antibodies, the association is still controversial. |
Page: 1